Messier Terri , Cech Bradley , Dzialo Joanna , Gibson Victoria , Poile Charlotte , Nakas Apostolos , Kutywayo Kudzayi , Bzura Aleksandra , Rogel Jan , Naumov George , Landry Christopher , Fennell Dean , Cunniff Brian
{"title":"同类首创的PRX3抑制剂RSO-021通过诱导免疫调节和降低上皮-间充质蛋白表达来调节恶性胸腔积液的组成","authors":"Messier Terri , Cech Bradley , Dzialo Joanna , Gibson Victoria , Poile Charlotte , Nakas Apostolos , Kutywayo Kudzayi , Bzura Aleksandra , Rogel Jan , Naumov George , Landry Christopher , Fennell Dean , Cunniff Brian","doi":"10.1016/j.lungcan.2025.108184","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"200 ","pages":"Article 108184"},"PeriodicalIF":4.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"74 The first-in-class PRX3 inhibitor RSO-021 modulates the composition of malignant pleural effusions by eliciting immunomodulation and decreasing epithelial to mesenchymal protein expression\",\"authors\":\"Messier Terri , Cech Bradley , Dzialo Joanna , Gibson Victoria , Poile Charlotte , Nakas Apostolos , Kutywayo Kudzayi , Bzura Aleksandra , Rogel Jan , Naumov George , Landry Christopher , Fennell Dean , Cunniff Brian\",\"doi\":\"10.1016/j.lungcan.2025.108184\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18129,\"journal\":{\"name\":\"Lung Cancer\",\"volume\":\"200 \",\"pages\":\"Article 108184\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0169500225001576\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500225001576","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
74 The first-in-class PRX3 inhibitor RSO-021 modulates the composition of malignant pleural effusions by eliciting immunomodulation and decreasing epithelial to mesenchymal protein expression
期刊介绍:
Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.